nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2B—cardial valve—systemic lupus erythematosus	0.0615	0.191	CbGeAlD
Lisuride—HTR2C—choroid plexus—systemic lupus erythematosus	0.0528	0.164	CbGeAlD
Lisuride—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0289	0.12	CbGbCtD
Lisuride—HTR2A—choroid plexus—systemic lupus erythematosus	0.0265	0.0822	CbGeAlD
Lisuride—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0261	0.108	CbGbCtD
Lisuride—CYP3A4—Dapsone—systemic lupus erythematosus	0.0253	0.105	CbGbCtD
Lisuride—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0219	0.0908	CbGbCtD
Lisuride—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0219	0.0908	CbGbCtD
Lisuride—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0188	0.0779	CbGbCtD
Lisuride—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0186	0.0768	CbGbCtD
Lisuride—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0176	0.0728	CbGbCtD
Lisuride—CYP3A4—Prednisone—systemic lupus erythematosus	0.0175	0.0726	CbGbCtD
Lisuride—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0172	0.0712	CbGbCtD
Lisuride—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0166	0.0688	CbGbCtD
Lisuride—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0109	0.0453	CbGbCtD
Lisuride—HTR2A—urine—systemic lupus erythematosus	0.00709	0.022	CbGeAlD
Lisuride—CYP3A4—urine—systemic lupus erythematosus	0.00656	0.0204	CbGeAlD
Lisuride—CYP2D6—urine—systemic lupus erythematosus	0.00645	0.02	CbGeAlD
Lisuride—HTR1A—blood plasma—systemic lupus erythematosus	0.0062	0.0193	CbGeAlD
Lisuride—DRD5—lymphoid tissue—systemic lupus erythematosus	0.00483	0.015	CbGeAlD
Lisuride—ADRA1B—kidney—systemic lupus erythematosus	0.00461	0.0143	CbGeAlD
Lisuride—ADRA2A—blood plasma—systemic lupus erythematosus	0.00435	0.0135	CbGeAlD
Lisuride—HTR2A—endothelium—systemic lupus erythematosus	0.00416	0.0129	CbGeAlD
Lisuride—HTR1D—connective tissue—systemic lupus erythematosus	0.00396	0.0123	CbGeAlD
Lisuride—DRD3—nervous system—systemic lupus erythematosus	0.00394	0.0122	CbGeAlD
Lisuride—ADRB1—connective tissue—systemic lupus erythematosus	0.00385	0.0119	CbGeAlD
Lisuride—DRD3—central nervous system—systemic lupus erythematosus	0.00379	0.0118	CbGeAlD
Lisuride—HTR2A—blood plasma—systemic lupus erythematosus	0.0037	0.0115	CbGeAlD
Lisuride—DRD5—nervous system—systemic lupus erythematosus	0.00369	0.0115	CbGeAlD
Lisuride—DRD5—central nervous system—systemic lupus erythematosus	0.00356	0.011	CbGeAlD
Lisuride—CYP3A4—blood plasma—systemic lupus erythematosus	0.00342	0.0106	CbGeAlD
Lisuride—HTR1D—kidney—systemic lupus erythematosus	0.00337	0.0105	CbGeAlD
Lisuride—CYP2D6—blood plasma—systemic lupus erythematosus	0.00337	0.0105	CbGeAlD
Lisuride—HTR2B—skin of body—systemic lupus erythematosus	0.00333	0.0103	CbGeAlD
Lisuride—HTR2B—cortex of kidney—systemic lupus erythematosus	0.00306	0.00948	CbGeAlD
Lisuride—ADRA1B—nervous system—systemic lupus erythematosus	0.00303	0.00939	CbGeAlD
Lisuride—ADRA1D—nervous system—systemic lupus erythematosus	0.00296	0.00919	CbGeAlD
Lisuride—ADRA1B—central nervous system—systemic lupus erythematosus	0.00291	0.00904	CbGeAlD
Lisuride—ADRA1D—central nervous system—systemic lupus erythematosus	0.00285	0.00885	CbGeAlD
Lisuride—DRD1—nervous system—systemic lupus erythematosus	0.00282	0.00876	CbGeAlD
Lisuride—ADRA2C—nephron tubule—systemic lupus erythematosus	0.00281	0.00872	CbGeAlD
Lisuride—DRD1—central nervous system—systemic lupus erythematosus	0.00272	0.00843	CbGeAlD
Lisuride—HTR2B—tendon—systemic lupus erythematosus	0.00253	0.00786	CbGeAlD
Lisuride—ADRA2C—kidney—systemic lupus erythematosus	0.00247	0.00766	CbGeAlD
Lisuride—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00241	0.00746	CbGeAlD
Lisuride—ADRB1—lung—systemic lupus erythematosus	0.00232	0.00721	CbGeAlD
Lisuride—ADRA2A—connective tissue—systemic lupus erythematosus	0.00232	0.00718	CbGeAlD
Lisuride—HTR1B—nervous system—systemic lupus erythematosus	0.00229	0.00709	CbGeAlD
Lisuride—HTR2B—lung—systemic lupus erythematosus	0.00222	0.0069	CbGeAlD
Lisuride—HTR1D—nervous system—systemic lupus erythematosus	0.00221	0.00687	CbGeAlD
Lisuride—HTR1B—central nervous system—systemic lupus erythematosus	0.0022	0.00683	CbGeAlD
Lisuride—HTR2C—nervous system—systemic lupus erythematosus	0.00219	0.0068	CbGeAlD
Lisuride—ADRB1—nervous system—systemic lupus erythematosus	0.00215	0.00667	CbGeAlD
Lisuride—HTR1D—central nervous system—systemic lupus erythematosus	0.00213	0.00661	CbGeAlD
Lisuride—HTR2C—central nervous system—systemic lupus erythematosus	0.00211	0.00655	CbGeAlD
Lisuride—ADRB1—central nervous system—systemic lupus erythematosus	0.00207	0.00643	CbGeAlD
Lisuride—HTR2B—nervous system—systemic lupus erythematosus	0.00206	0.00639	CbGeAlD
Lisuride—ADRA2C—tendon—systemic lupus erythematosus	0.00199	0.00619	CbGeAlD
Lisuride—HTR2B—central nervous system—systemic lupus erythematosus	0.00198	0.00615	CbGeAlD
Lisuride—HTR2A—connective tissue—systemic lupus erythematosus	0.00197	0.00611	CbGeAlD
Lisuride—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.00192	0.00596	CbGeAlD
Lisuride—HTR1A—nervous system—systemic lupus erythematosus	0.00185	0.00573	CbGeAlD
Lisuride—DRD2—lung—systemic lupus erythematosus	0.0018	0.00559	CbGeAlD
Lisuride—HTR1A—central nervous system—systemic lupus erythematosus	0.00178	0.00551	CbGeAlD
Lisuride—ADRA2C—lung—systemic lupus erythematosus	0.00175	0.00543	CbGeAlD
Lisuride—HTR2A—kidney—systemic lupus erythematosus	0.00168	0.0052	CbGeAlD
Lisuride—DRD2—nervous system—systemic lupus erythematosus	0.00167	0.00517	CbGeAlD
Lisuride—ADRA2C—nervous system—systemic lupus erythematosus	0.00162	0.00503	CbGeAlD
Lisuride—Weight decreased—Mycophenolate mofetil—systemic lupus erythematosus	0.00161	0.00484	CcSEcCtD
Lisuride—DRD2—central nervous system—systemic lupus erythematosus	0.00161	0.00498	CbGeAlD
Lisuride—Vomiting—Dapsone—systemic lupus erythematosus	0.0016	0.00481	CcSEcCtD
Lisuride—ADRA2A—tendon—systemic lupus erythematosus	0.00159	0.00494	CbGeAlD
Lisuride—Headache—Dapsone—systemic lupus erythematosus	0.00158	0.00474	CcSEcCtD
Lisuride—ADRA2C—central nervous system—systemic lupus erythematosus	0.00156	0.00484	CbGeAlD
Lisuride—CYP3A4—kidney—systemic lupus erythematosus	0.00155	0.00481	CbGeAlD
Lisuride—CYP2D6—kidney—systemic lupus erythematosus	0.00153	0.00474	CbGeAlD
Lisuride—Sweating—Mycophenolate mofetil—systemic lupus erythematosus	0.00152	0.00457	CcSEcCtD
Lisuride—Weight increased—Prednisolone—systemic lupus erythematosus	0.00151	0.00454	CcSEcCtD
Lisuride—Vertigo—Leflunomide—systemic lupus erythematosus	0.00148	0.00445	CcSEcCtD
Lisuride—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.00147	0.00444	CcSEcCtD
Lisuride—Weight decreased—Hydrocortisone—systemic lupus erythematosus	0.00147	0.00441	CcSEcCtD
Lisuride—Palpitations—Leflunomide—systemic lupus erythematosus	0.00145	0.00438	CcSEcCtD
Lisuride—Cough—Leflunomide—systemic lupus erythematosus	0.00144	0.00432	CcSEcCtD
Lisuride—Hallucination—Mycophenolate mofetil—systemic lupus erythematosus	0.00142	0.00426	CcSEcCtD
Lisuride—Infection—Azathioprine—systemic lupus erythematosus	0.00141	0.00425	CcSEcCtD
Lisuride—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.0014	0.00422	CcSEcCtD
Lisuride—ADRA2A—lung—systemic lupus erythematosus	0.0014	0.00433	CbGeAlD
Lisuride—Anxiety—Leflunomide—systemic lupus erythematosus	0.0014	0.0042	CcSEcCtD
Lisuride—Weight increased—Triamcinolone—systemic lupus erythematosus	0.00139	0.00418	CcSEcCtD
Lisuride—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.00139	0.00417	CcSEcCtD
Lisuride—Dry mouth—Leflunomide—systemic lupus erythematosus	0.00137	0.00412	CcSEcCtD
Lisuride—HTR2A—tendon—systemic lupus erythematosus	0.00135	0.0042	CbGeAlD
Lisuride—Infection—Leflunomide—systemic lupus erythematosus	0.00133	0.00402	CcSEcCtD
Lisuride—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.00132	0.00398	CcSEcCtD
Lisuride—Cardiac disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00132	0.00397	CcSEcCtD
Lisuride—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.00132	0.00396	CcSEcCtD
Lisuride—Mediastinal disorder—Cyclosporine—systemic lupus erythematosus	0.00132	0.00396	CcSEcCtD
Lisuride—Tachycardia—Leflunomide—systemic lupus erythematosus	0.00131	0.00394	CcSEcCtD
Lisuride—Sweating—Methylprednisolone—systemic lupus erythematosus	0.0013	0.00391	CcSEcCtD
Lisuride—Hyperhidrosis—Leflunomide—systemic lupus erythematosus	0.0013	0.00391	CcSEcCtD
Lisuride—ADRA2A—nervous system—systemic lupus erythematosus	0.00129	0.00401	CbGeAlD
Lisuride—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.00129	0.00389	CcSEcCtD
Lisuride—Hallucination—Hydrocortisone—systemic lupus erythematosus	0.00129	0.00388	CcSEcCtD
Lisuride—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00128	0.00386	CcSEcCtD
Lisuride—Anorexia—Leflunomide—systemic lupus erythematosus	0.00128	0.00385	CcSEcCtD
Lisuride—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.00128	0.00385	CcSEcCtD
Lisuride—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.00127	0.00382	CcSEcCtD
Lisuride—Weight increased—Betamethasone—systemic lupus erythematosus	0.00126	0.00379	CcSEcCtD
Lisuride—Weight increased—Dexamethasone—systemic lupus erythematosus	0.00126	0.00379	CcSEcCtD
Lisuride—Weight decreased—Betamethasone—systemic lupus erythematosus	0.00125	0.00377	CcSEcCtD
Lisuride—Weight decreased—Dexamethasone—systemic lupus erythematosus	0.00125	0.00377	CcSEcCtD
Lisuride—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00125	0.00375	CcSEcCtD
Lisuride—ADRA2A—central nervous system—systemic lupus erythematosus	0.00125	0.00386	CbGeAlD
Lisuride—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.00124	0.00373	CcSEcCtD
Lisuride—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.00123	0.00369	CcSEcCtD
Lisuride—Insomnia—Leflunomide—systemic lupus erythematosus	0.00122	0.00366	CcSEcCtD
Lisuride—Hallucination—Methylprednisolone—systemic lupus erythematosus	0.00121	0.00365	CcSEcCtD
Lisuride—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.0012	0.0036	CcSEcCtD
Lisuride—HTR2A—lung—systemic lupus erythematosus	0.00119	0.00368	CbGeAlD
Lisuride—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.00117	0.00353	CcSEcCtD
Lisuride—Immune system disorder—Hydrocortisone—systemic lupus erythematosus	0.00117	0.00352	CcSEcCtD
Lisuride—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.00117	0.00351	CcSEcCtD
Lisuride—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00116	0.00349	CcSEcCtD
Lisuride—Fatigue—Leflunomide—systemic lupus erythematosus	0.00116	0.00348	CcSEcCtD
Lisuride—Constipation—Leflunomide—systemic lupus erythematosus	0.00115	0.00346	CcSEcCtD
Lisuride—Vertigo—Cyclosporine—systemic lupus erythematosus	0.00114	0.00343	CcSEcCtD
Lisuride—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.00114	0.00342	CcSEcCtD
Lisuride—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.00113	0.0034	CcSEcCtD
Lisuride—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.00113	0.0034	CcSEcCtD
Lisuride—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.00111	0.00335	CcSEcCtD
Lisuride—Syncope—Mycophenolate mofetil—systemic lupus erythematosus	0.00111	0.00334	CcSEcCtD
Lisuride—Cough—Cyclosporine—systemic lupus erythematosus	0.00111	0.00333	CcSEcCtD
Lisuride—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.00111	0.00333	CcSEcCtD
Lisuride—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.00111	0.00333	CcSEcCtD
Lisuride—Hallucination—Dexamethasone—systemic lupus erythematosus	0.0011	0.00332	CcSEcCtD
Lisuride—Hallucination—Betamethasone—systemic lupus erythematosus	0.0011	0.00332	CcSEcCtD
Lisuride—Immune system disorder—Methylprednisolone—systemic lupus erythematosus	0.0011	0.00331	CcSEcCtD
Lisuride—HTR2A—nervous system—systemic lupus erythematosus	0.0011	0.00341	CbGeAlD
Lisuride—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.0011	0.0033	CcSEcCtD
Lisuride—Weight increased—Prednisone—systemic lupus erythematosus	0.0011	0.0033	CcSEcCtD
Lisuride—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.0011	0.00329	CcSEcCtD
Lisuride—Weight decreased—Prednisone—systemic lupus erythematosus	0.00109	0.00328	CcSEcCtD
Lisuride—Cough—Mycophenolate mofetil—systemic lupus erythematosus	0.00108	0.00325	CcSEcCtD
Lisuride—Anxiety—Cyclosporine—systemic lupus erythematosus	0.00108	0.00324	CcSEcCtD
Lisuride—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.00107	0.00321	CcSEcCtD
Lisuride—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.00106	0.00319	CcSEcCtD
Lisuride—HTR2A—central nervous system—systemic lupus erythematosus	0.00106	0.00328	CbGeAlD
Lisuride—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.00106	0.00318	CcSEcCtD
Lisuride—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.00105	0.00316	CcSEcCtD
Lisuride—Confusional state—Cyclosporine—systemic lupus erythematosus	0.00105	0.00314	CcSEcCtD
Lisuride—Vertigo—Prednisolone—systemic lupus erythematosus	0.00104	0.00312	CcSEcCtD
Lisuride—Syncope—Prednisolone—systemic lupus erythematosus	0.00104	0.00312	CcSEcCtD
Lisuride—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.00103	0.0031	CcSEcCtD
Lisuride—Infection—Cyclosporine—systemic lupus erythematosus	0.00103	0.0031	CcSEcCtD
Lisuride—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.00102	0.00307	CcSEcCtD
Lisuride—CYP3A4—nervous system—systemic lupus erythematosus	0.00102	0.00316	CbGeAlD
Lisuride—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.00102	0.00306	CcSEcCtD
Lisuride—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.00101	0.00305	CcSEcCtD
Lisuride—Syncope—Hydrocortisone—systemic lupus erythematosus	0.00101	0.00305	CcSEcCtD
Lisuride—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00101	0.00302	CcSEcCtD
Lisuride—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00101	0.00302	CcSEcCtD
Lisuride—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.001	0.00302	CcSEcCtD
Lisuride—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.001	0.00302	CcSEcCtD
Lisuride—CYP2D6—nervous system—systemic lupus erythematosus	0.001	0.00311	CbGeAlD
Lisuride—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000992	0.00298	CcSEcCtD
Lisuride—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000988	0.00297	CcSEcCtD
Lisuride—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000987	0.00297	CcSEcCtD
Lisuride—CYP3A4—central nervous system—systemic lupus erythematosus	0.00098	0.00304	CbGeAlD
Lisuride—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000978	0.00294	CcSEcCtD
Lisuride—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000966	0.00291	CcSEcCtD
Lisuride—CYP2D6—central nervous system—systemic lupus erythematosus	0.000964	0.00299	CbGeAlD
Lisuride—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000964	0.0029	CcSEcCtD
Lisuride—Asthenia—Leflunomide—systemic lupus erythematosus	0.000964	0.0029	CcSEcCtD
Lisuride—Hallucination—Prednisone—systemic lupus erythematosus	0.00096	0.00289	CcSEcCtD
Lisuride—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000958	0.00288	CcSEcCtD
Lisuride—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000955	0.00287	CcSEcCtD
Lisuride—Syncope—Triamcinolone—systemic lupus erythematosus	0.000953	0.00287	CcSEcCtD
Lisuride—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000953	0.00287	CcSEcCtD
Lisuride—Syncope—Methylprednisolone—systemic lupus erythematosus	0.000951	0.00286	CcSEcCtD
Lisuride—Dizziness—Azathioprine—systemic lupus erythematosus	0.000941	0.00283	CcSEcCtD
Lisuride—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000938	0.00282	CcSEcCtD
Lisuride—Cough—Triamcinolone—systemic lupus erythematosus	0.000928	0.00279	CcSEcCtD
Lisuride—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000924	0.00278	CcSEcCtD
Lisuride—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000922	0.00277	CcSEcCtD
Lisuride—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000921	0.00277	CcSEcCtD
Lisuride—Infection—Hydrocortisone—systemic lupus erythematosus	0.000915	0.00275	CcSEcCtD
Lisuride—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000915	0.00275	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000912	0.00274	CcSEcCtD
Lisuride—Vomiting—Azathioprine—systemic lupus erythematosus	0.000904	0.00272	CcSEcCtD
Lisuride—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000904	0.00272	CcSEcCtD
Lisuride—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000902	0.00271	CcSEcCtD
Lisuride—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000901	0.00271	CcSEcCtD
Lisuride—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.0009	0.00271	CcSEcCtD
Lisuride—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000899	0.00271	CcSEcCtD
Lisuride—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000899	0.0027	CcSEcCtD
Lisuride—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000895	0.00269	CcSEcCtD
Lisuride—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000894	0.00269	CcSEcCtD
Lisuride—Headache—Azathioprine—systemic lupus erythematosus	0.000891	0.00268	CcSEcCtD
Lisuride—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000891	0.00268	CcSEcCtD
Lisuride—Dizziness—Leflunomide—systemic lupus erythematosus	0.000888	0.00267	CcSEcCtD
Lisuride—Constipation—Cyclosporine—systemic lupus erythematosus	0.000887	0.00267	CcSEcCtD
Lisuride—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000885	0.00266	CcSEcCtD
Lisuride—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000879	0.00264	CcSEcCtD
Lisuride—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000878	0.00264	CcSEcCtD
Lisuride—Angiopathy—Prednisone—systemic lupus erythematosus	0.000875	0.00263	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000873	0.00263	CcSEcCtD
Lisuride—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000873	0.00263	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000872	0.00262	CcSEcCtD
Lisuride—Vertigo—Betamethasone—systemic lupus erythematosus	0.000867	0.00261	CcSEcCtD
Lisuride—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000867	0.00261	CcSEcCtD
Lisuride—Syncope—Dexamethasone—systemic lupus erythematosus	0.000865	0.0026	CcSEcCtD
Lisuride—Syncope—Betamethasone—systemic lupus erythematosus	0.000865	0.0026	CcSEcCtD
Lisuride—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000865	0.0026	CcSEcCtD
Lisuride—Infection—Triamcinolone—systemic lupus erythematosus	0.000862	0.00259	CcSEcCtD
Lisuride—Sweating—Methotrexate—systemic lupus erythematosus	0.000861	0.00259	CcSEcCtD
Lisuride—Infection—Methylprednisolone—systemic lupus erythematosus	0.00086	0.00259	CcSEcCtD
Lisuride—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000854	0.00257	CcSEcCtD
Lisuride—Vomiting—Leflunomide—systemic lupus erythematosus	0.000854	0.00257	CcSEcCtD
Lisuride—Insomnia—Prednisolone—systemic lupus erythematosus	0.000853	0.00257	CcSEcCtD
Lisuride—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000849	0.00255	CcSEcCtD
Lisuride—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000847	0.00255	CcSEcCtD
Lisuride—Mental disorder—Prednisone—systemic lupus erythematosus	0.000845	0.00254	CcSEcCtD
Lisuride—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000845	0.00254	CcSEcCtD
Lisuride—Headache—Leflunomide—systemic lupus erythematosus	0.000842	0.00253	CcSEcCtD
Lisuride—Malnutrition—Prednisone—systemic lupus erythematosus	0.00084	0.00253	CcSEcCtD
Lisuride—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000839	0.00252	CcSEcCtD
Lisuride—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000837	0.00252	CcSEcCtD
Lisuride—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000833	0.00251	CcSEcCtD
Lisuride—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000833	0.00251	CcSEcCtD
Lisuride—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000818	0.00246	CcSEcCtD
Lisuride—Anxiety—Betamethasone—systemic lupus erythematosus	0.000818	0.00246	CcSEcCtD
Lisuride—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000801	0.00241	CcSEcCtD
Lisuride—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000795	0.00239	CcSEcCtD
Lisuride—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000794	0.00239	CcSEcCtD
Lisuride—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000785	0.00236	CcSEcCtD
Lisuride—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000783	0.00236	CcSEcCtD
Lisuride—Infection—Betamethasone—systemic lupus erythematosus	0.000782	0.00235	CcSEcCtD
Lisuride—Infection—Dexamethasone—systemic lupus erythematosus	0.000782	0.00235	CcSEcCtD
Lisuride—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000777	0.00234	CcSEcCtD
Lisuride—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000773	0.00233	CcSEcCtD
Lisuride—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000772	0.00232	CcSEcCtD
Lisuride—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000772	0.00232	CcSEcCtD
Lisuride—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000768	0.00231	CcSEcCtD
Lisuride—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000768	0.00231	CcSEcCtD
Lisuride—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000761	0.00229	CcSEcCtD
Lisuride—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000761	0.00229	CcSEcCtD
Lisuride—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000759	0.00228	CcSEcCtD
Lisuride—Vertigo—Prednisone—systemic lupus erythematosus	0.000755	0.00227	CcSEcCtD
Lisuride—Syncope—Prednisone—systemic lupus erythematosus	0.000753	0.00227	CcSEcCtD
Lisuride—Anorexia—Dexamethasone—systemic lupus erythematosus	0.00075	0.00226	CcSEcCtD
Lisuride—Anorexia—Betamethasone—systemic lupus erythematosus	0.00075	0.00226	CcSEcCtD
Lisuride—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000748	0.00225	CcSEcCtD
Lisuride—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000748	0.00225	CcSEcCtD
Lisuride—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000746	0.00225	CcSEcCtD
Lisuride—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000744	0.00224	CcSEcCtD
Lisuride—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000732	0.0022	CcSEcCtD
Lisuride—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000728	0.00219	CcSEcCtD
Lisuride—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000727	0.00219	CcSEcCtD
Lisuride—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000726	0.00218	CcSEcCtD
Lisuride—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000715	0.00215	CcSEcCtD
Lisuride—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000713	0.00215	CcSEcCtD
Lisuride—Anxiety—Prednisone—systemic lupus erythematosus	0.000713	0.00214	CcSEcCtD
Lisuride—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000712	0.00214	CcSEcCtD
Lisuride—Insomnia—Betamethasone—systemic lupus erythematosus	0.000712	0.00214	CcSEcCtD
Lisuride—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000707	0.00213	CcSEcCtD
Lisuride—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000702	0.00211	CcSEcCtD
Lisuride—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000686	0.00206	CcSEcCtD
Lisuride—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000684	0.00206	CcSEcCtD
Lisuride—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000684	0.00206	CcSEcCtD
Lisuride—Infection—Prednisone—systemic lupus erythematosus	0.000681	0.00205	CcSEcCtD
Lisuride—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00068	0.00204	CcSEcCtD
Lisuride—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00068	0.00204	CcSEcCtD
Lisuride—Fatigue—Betamethasone—systemic lupus erythematosus	0.000679	0.00204	CcSEcCtD
Lisuride—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000679	0.00204	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000672	0.00202	CcSEcCtD
Lisuride—Tachycardia—Prednisone—systemic lupus erythematosus	0.000669	0.00201	CcSEcCtD
Lisuride—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000669	0.00201	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000663	0.00199	CcSEcCtD
Lisuride—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000661	0.00199	CcSEcCtD
Lisuride—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000659	0.00198	CcSEcCtD
Lisuride—Anorexia—Prednisone—systemic lupus erythematosus	0.000653	0.00197	CcSEcCtD
Lisuride—Headache—Cyclosporine—systemic lupus erythematosus	0.000649	0.00195	CcSEcCtD
Lisuride—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000649	0.00195	CcSEcCtD
Lisuride—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000649	0.00195	CcSEcCtD
Lisuride—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000643	0.00193	CcSEcCtD
Lisuride—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000634	0.00191	CcSEcCtD
Lisuride—Vertigo—Methotrexate—systemic lupus erythematosus	0.000631	0.0019	CcSEcCtD
Lisuride—Dizziness—Prednisolone—systemic lupus erythematosus	0.000624	0.00188	CcSEcCtD
Lisuride—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000622	0.00187	CcSEcCtD
Lisuride—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000621	0.00187	CcSEcCtD
Lisuride—Insomnia—Prednisone—systemic lupus erythematosus	0.00062	0.00187	CcSEcCtD
Lisuride—Cough—Methotrexate—systemic lupus erythematosus	0.000613	0.00184	CcSEcCtD
Lisuride—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000609	0.00183	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000596	0.00179	CcSEcCtD
Lisuride—Fatigue—Prednisone—systemic lupus erythematosus	0.000591	0.00178	CcSEcCtD
Lisuride—Headache—Prednisolone—systemic lupus erythematosus	0.000591	0.00178	CcSEcCtD
Lisuride—Constipation—Prednisone—systemic lupus erythematosus	0.000586	0.00176	CcSEcCtD
Lisuride—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000586	0.00176	CcSEcCtD
Lisuride—Confusional state—Methotrexate—systemic lupus erythematosus	0.000578	0.00174	CcSEcCtD
Lisuride—Headache—Hydrocortisone—systemic lupus erythematosus	0.000577	0.00174	CcSEcCtD
Lisuride—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000574	0.00173	CcSEcCtD
Lisuride—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000572	0.00172	CcSEcCtD
Lisuride—Infection—Methotrexate—systemic lupus erythematosus	0.000569	0.00171	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000565	0.0017	CcSEcCtD
Lisuride—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000565	0.0017	CcSEcCtD
Lisuride—Asthenia—Betamethasone—systemic lupus erythematosus	0.000565	0.0017	CcSEcCtD
Lisuride—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000562	0.00169	CcSEcCtD
Lisuride—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000554	0.00167	CcSEcCtD
Lisuride—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000552	0.00166	CcSEcCtD
Lisuride—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00055	0.00166	CcSEcCtD
Lisuride—Anorexia—Methotrexate—systemic lupus erythematosus	0.000546	0.00164	CcSEcCtD
Lisuride—Headache—Triamcinolone—systemic lupus erythematosus	0.000544	0.00164	CcSEcCtD
Lisuride—Headache—Methylprednisolone—systemic lupus erythematosus	0.000542	0.00163	CcSEcCtD
Lisuride—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000521	0.00157	CcSEcCtD
Lisuride—Dizziness—Betamethasone—systemic lupus erythematosus	0.000521	0.00157	CcSEcCtD
Lisuride—Insomnia—Methotrexate—systemic lupus erythematosus	0.000518	0.00156	CcSEcCtD
Lisuride—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000511	0.00154	CcSEcCtD
Lisuride—Somnolence—Methotrexate—systemic lupus erythematosus	0.000509	0.00153	CcSEcCtD
Lisuride—Vomiting—Betamethasone—systemic lupus erythematosus	0.000501	0.00151	CcSEcCtD
Lisuride—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000501	0.00151	CcSEcCtD
Lisuride—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000498	0.0015	CcSEcCtD
Lisuride—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000495	0.00149	CcSEcCtD
Lisuride—Fatigue—Methotrexate—systemic lupus erythematosus	0.000494	0.00149	CcSEcCtD
Lisuride—Headache—Betamethasone—systemic lupus erythematosus	0.000493	0.00148	CcSEcCtD
Lisuride—Headache—Dexamethasone—systemic lupus erythematosus	0.000493	0.00148	CcSEcCtD
Lisuride—Asthenia—Prednisone—systemic lupus erythematosus	0.000492	0.00148	CcSEcCtD
Lisuride—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000472	0.00142	CcSEcCtD
Lisuride—Dizziness—Prednisone—systemic lupus erythematosus	0.000453	0.00136	CcSEcCtD
Lisuride—Vomiting—Prednisone—systemic lupus erythematosus	0.000436	0.00131	CcSEcCtD
Lisuride—Headache—Prednisone—systemic lupus erythematosus	0.000429	0.00129	CcSEcCtD
Lisuride—Asthenia—Methotrexate—systemic lupus erythematosus	0.000411	0.00124	CcSEcCtD
Lisuride—Dizziness—Methotrexate—systemic lupus erythematosus	0.000379	0.00114	CcSEcCtD
Lisuride—Vomiting—Methotrexate—systemic lupus erythematosus	0.000364	0.0011	CcSEcCtD
Lisuride—Headache—Methotrexate—systemic lupus erythematosus	0.000359	0.00108	CcSEcCtD
Lisuride—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.06e-05	0.000198	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—JAK1—systemic lupus erythematosus	2.05e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.04e-05	0.000197	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PPARG—systemic lupus erythematosus	2.03e-05	0.000195	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NOS3—systemic lupus erythematosus	2.02e-05	0.000195	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.02e-05	0.000194	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.02e-05	0.000194	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EP300—systemic lupus erythematosus	2.01e-05	0.000193	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TYK2—systemic lupus erythematosus	1.98e-05	0.000191	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	1.98e-05	0.000191	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.98e-05	0.000191	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.98e-05	0.000191	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.97e-05	0.000189	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	1.97e-05	0.000189	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NOS3—systemic lupus erythematosus	1.95e-05	0.000187	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.94e-05	0.000187	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCL2—systemic lupus erythematosus	1.94e-05	0.000187	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCL2—systemic lupus erythematosus	1.94e-05	0.000187	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.91e-05	0.000184	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.91e-05	0.000184	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	1.9e-05	0.000183	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.9e-05	0.000183	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.9e-05	0.000183	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	1.9e-05	0.000183	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—F2—systemic lupus erythematosus	1.9e-05	0.000183	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TYK2—systemic lupus erythematosus	1.89e-05	0.000182	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	1.89e-05	0.000182	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	1.88e-05	0.000181	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.88e-05	0.000181	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.87e-05	0.00018	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	1.87e-05	0.00018	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	1.87e-05	0.00018	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.86e-05	0.000179	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-05	0.000177	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	1.83e-05	0.000177	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—systemic lupus erythematosus	1.82e-05	0.000176	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.82e-05	0.000175	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	1.81e-05	0.000174	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	1.81e-05	0.000174	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.79e-05	0.000172	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.77e-05	0.00017	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TYK2—systemic lupus erythematosus	1.76e-05	0.00017	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TYK2—systemic lupus erythematosus	1.76e-05	0.00017	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CD80—systemic lupus erythematosus	1.76e-05	0.000169	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.75e-05	0.000169	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	1.75e-05	0.000169	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.75e-05	0.000169	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.74e-05	0.000168	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—NOS3—systemic lupus erythematosus	1.74e-05	0.000168	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.74e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	1.73e-05	0.000167	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	1.73e-05	0.000167	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NOS3—systemic lupus erythematosus	1.73e-05	0.000167	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.71e-05	0.000165	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL2—systemic lupus erythematosus	1.71e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.71e-05	0.000165	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—systemic lupus erythematosus	1.7e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	1.7e-05	0.000164	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.7e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	1.7e-05	0.000164	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.69e-05	0.000163	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.69e-05	0.000162	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	1.68e-05	0.000162	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.68e-05	0.000162	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.67e-05	0.000161	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	1.67e-05	0.00016	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL2—systemic lupus erythematosus	1.65e-05	0.000159	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	1.65e-05	0.000159	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—systemic lupus erythematosus	1.64e-05	0.000158	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	1.64e-05	0.000158	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-05	0.000158	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MMP9—systemic lupus erythematosus	1.62e-05	0.000156	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.62e-05	0.000156	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	1.61e-05	0.000155	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.61e-05	0.000155	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.61e-05	0.000155	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	1.6e-05	0.000154	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	1.6e-05	0.000154	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	1.59e-05	0.000153	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.59e-05	0.000153	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.58e-05	0.000152	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.58e-05	0.000152	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL2—systemic lupus erythematosus	1.58e-05	0.000152	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	1.57e-05	0.000151	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.57e-05	0.000151	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	1.56e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.56e-05	0.00015	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.56e-05	0.00015	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	1.54e-05	0.000148	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.54e-05	0.000148	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	1.53e-05	0.000147	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.52e-05	0.000146	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.51e-05	0.000145	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.5e-05	0.000145	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	1.5e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.5e-05	0.000144	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.5e-05	0.000144	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.49e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	1.49e-05	0.000144	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.49e-05	0.000143	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	1.49e-05	0.000143	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-05	0.000143	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.48e-05	0.000143	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	1.48e-05	0.000143	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	1.48e-05	0.000143	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.48e-05	0.000142	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	1.47e-05	0.000141	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	1.47e-05	0.000141	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	1.46e-05	0.000141	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.46e-05	0.000141	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	1.46e-05	0.00014	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.46e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-05	0.00014	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.46e-05	0.00014	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.44e-05	0.000138	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	1.43e-05	0.000138	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.43e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	1.42e-05	0.000136	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EP300—systemic lupus erythematosus	1.41e-05	0.000136	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.41e-05	0.000135	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.4e-05	0.000135	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.4e-05	0.000135	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	1.39e-05	0.000134	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.39e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.38e-05	0.000133	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.38e-05	0.000133	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.36e-05	0.000131	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.35e-05	0.00013	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.35e-05	0.00013	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.34e-05	0.000129	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.34e-05	0.000129	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	1.34e-05	0.000129	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	1.33e-05	0.000128	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.33e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.33e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	1.33e-05	0.000128	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.33e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	1.32e-05	0.000127	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.32e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.32e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	1.32e-05	0.000127	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	1.32e-05	0.000127	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	1.31e-05	0.000127	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.31e-05	0.000126	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.31e-05	0.000126	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.3e-05	0.000125	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.3e-05	0.000125	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	1.3e-05	0.000125	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.29e-05	0.000124	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.28e-05	0.000123	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.27e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.27e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.26e-05	0.000122	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.26e-05	0.000122	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.26e-05	0.000122	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.26e-05	0.000122	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.26e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.25e-05	0.000121	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.25e-05	0.00012	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.25e-05	0.00012	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.25e-05	0.00012	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.24e-05	0.00012	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.23e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.23e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.22e-05	0.000117	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.21e-05	0.000117	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.21e-05	0.000116	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.21e-05	0.000116	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.2e-05	0.000116	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.2e-05	0.000116	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.2e-05	0.000115	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	1.2e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	1.19e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.18e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-05	0.000112	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.16e-05	0.000112	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.15e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.15e-05	0.00011	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.15e-05	0.00011	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.15e-05	0.00011	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.14e-05	0.00011	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.14e-05	0.00011	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.14e-05	0.00011	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.14e-05	0.000109	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.13e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.12e-05	0.000108	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	1.12e-05	0.000108	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.12e-05	0.000107	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.11e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-05	0.000107	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.1e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.1e-05	0.000106	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.09e-05	0.000105	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.09e-05	0.000105	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.08e-05	0.000104	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	1.08e-05	0.000104	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.07e-05	0.000103	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.06e-05	0.000102	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.06e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-05	0.000101	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.04e-05	0.000101	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.04e-05	0.0001	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.04e-05	0.0001	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.03e-05	9.96e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.03e-05	9.94e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.03e-05	9.88e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.01e-05	9.7e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	1.01e-05	9.69e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1e-05	9.67e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	9.99e-06	9.62e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.97e-06	9.6e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.91e-06	9.55e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	9.9e-06	9.54e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	9.86e-06	9.49e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	9.7e-06	9.34e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	9.65e-06	9.29e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.64e-06	9.29e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.53e-06	9.18e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	9.5e-06	9.15e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.49e-06	9.14e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.47e-06	9.12e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.38e-06	9.03e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—systemic lupus erythematosus	9.26e-06	8.92e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	9.23e-06	8.89e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	9.01e-06	8.68e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.75e-06	8.43e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	8.73e-06	8.41e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	8.62e-06	8.3e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	8.62e-06	8.3e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.61e-06	8.29e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.53e-06	8.22e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	8.44e-06	8.13e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	7.85e-06	7.56e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.83e-06	7.54e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	7.78e-06	7.49e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	7.51e-06	7.23e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	7.47e-06	7.19e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	7.27e-06	7e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	7.15e-06	6.89e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	7.02e-06	6.76e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	7.02e-06	6.76e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	6.59e-06	6.35e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	6.49e-06	6.25e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.31e-06	6.08e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	6.04e-06	5.81e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	5.9e-06	5.68e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.52e-06	5.32e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.59e-06	4.42e-05	CbGpPWpGaD
